All Articles

Yuyu Pharma's quiet entry into the U.S. isn't just about cat supplements. It's a masterclass in strategic infiltration, using a UCLA incubator to de-risk a billion-dollar bet.

The DermCare and USDP merger creates a dermatology behemoth. What does this consolidation mean for patients, doctors, and the future of specialized care?

ZincFive's SPAC merger isn't just a deal; it's a bet on the critical battery chemistry needed to sustain the world's insatiable AI power demands.

As BRP Inc. preps for its Q2 earnings call, the powersports giant faces major tariff headwinds despite strong innovation in its new electric vehicle lineup.

A new study shows AI is now standard in IT transformation. But as firms chase innovation, an old problem—poor data quality—threatens to derail progress.

As software supply chain attacks escalate, one company is on a strategic tour to prove its solution, promising to eliminate nearly all vulnerabilities.

CAI Software's acquisition of LLumin isn't just another deal. It's a strategic move to build an integrated platform that tackles manufacturing's biggest cost.

The IRS awarded a major contract to TTEC to modernize its contact centers with AI. Can private sector tech finally solve decades of taxpayer frustration?

A landmark survey reveals Republicans and Democrats in key states overwhelmingly agree on federal family support, challenging the narrative of a divided America.

A niche software firm just unlocked the federal market in weeks, not years. Their secret weapon? An AI platform that turns a dreaded security gauntlet into a strategic advantage.

Unanimous AI's new Hyperlingual platform enables real-time, multi-language debates, promising to unlock global collaboration and trapped economic value.

With its new Bogotá center, Auxis taps into Colombia's booming bilingual talent pool, offering U.S. businesses a resilient alternative to far-flung operations.

Two firms unite to form Endure, a national platform for critical power. They promise seamless service, but in a world reliant on data, the real test is just beginning.

Landing on the Inc. 5000 is just the headline. The real story is how iScribeHealth's ambient AI is tackling healthcare's $43B paperwork crisis.

Air India is using AI to ask passengers to switch flights for perks. It's a key part of its massive turnaround, turning overbooking from a headache into a choice.

A Kansas City CCRC's pivot from hefty entrance fees to a rental model reveals a strategic play by new owner Lapis Advisers, a blueprint for the industry.

Advanced Flower Capital's Q2 saw Net Asset Value rise, thanks to a savvy share buyback. But a drop in net investment income reveals a complex transition.

A landmark study proves the link between environmental action and financial performance is not direct, but flows through a powerful new channel: consumer sales.

Q2 data reveals a stark divergence: private markets show steady, earnings-driven growth while public markets chase AI hype. But beneath the surface, a new era of selectivity emerges.

NervGen Pharma launches its pivotal Phase 3 RESTORE trial for spinal cord injury, backed by $61M in cash and new leadership, igniting hope for a new era of neuro-repair.